Summary
Bristol-Myers Squibb (BMY) filed an 8-K on April 25, 2019, to announce its first-quarter 2019 financial results. The core of this filing is the earnings press release, which provides detailed financial performance data. Investors should note that this report primarily serves to disseminate the official Q1 2019 earnings information, with additional supplemental data also made available on the company's website.
Key Highlights
- 1Bristol-Myers Squibb announced its financial results for the first quarter of 2019.
- 2The 8-K filing includes the official earnings press release.
- 3The press release details the company's financial condition and results of operations for Q1 2019.
- 4Supplemental financial information is also available on the company's website.
- 5This filing is primarily an informational update regarding the company's latest earnings performance.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally announce and provide access to Bristol-Myers Squibb's financial results for the first quarter of 2019 through an attached earnings press release.
The detailed financial results for Q1 2019 can be found in the press release filed as Exhibit 99.1 with this 8-K. Additional supplemental information is also available on the company's website at www.bms.com.
This particular 8-K filing focuses solely on the dissemination of Q1 2019 financial results. It does not appear to contain new strategic announcements or major business updates beyond the earnings report itself.